Forge Biologics and Labcorp announce strategic AAV gene therapy development and manufacturing collaboration

Closing laboratory information gaps to increase point of care clinical insights

Lab values are estimated to fuel 70% of clinical decisions, but accessing patient lab results residing outside an organization’s EHR presents an administrative challenge and burden for clinicians. This presentation explores how a single view of patient lab values, consolidating data from both the EHR and a national unified and standardized lab database at the point of care, can reduce the information gap, helping clinicians more effectively and efficiently manage patients and close care gaps. 

Labcorp awarded Forrester Research 2023 Customer Obsession Leadership Award

BURLINGTON, N.C. , June 14, 2023 /PRNewswire/ --  Labcorp  (NYSE: LH), a leading global life sciences company, is pleased to share that its executive vice president and chief marketing officer, Amy Summy , has been awarded the inaugural Forrester Customer Obsession Leadership Award, recognizing

Labcorp announces pricing of Fortrea $570 million Notes Offering in connection with anticipated Fortrea spinoff

BURLINGTON, N.C. , June 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc. , a wholly owned subsidiary of Labcorp ("Fortrea"), has priced an offering of $570 million of senior secured notes due 2030 (the "Notes"), in

Labcorp announces additional information in connection with its spin-off of Fortrea

BURLINGTON, N.C. , June 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, previously announced the following record and distribution dates for its spin-off of Fortrea Holdings Inc. , a wholly owned subsidiary of Labcorp ("Fortrea"): The record date will be 5:00

Labcorp announces information in connection with its spin-off of Fortrea

BURLINGTON, N.C. , June 9, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the following record and distribution dates for the spin-off of Fortrea Holdings Inc. , a wholly owned subsidiary of Labcorp ("Fortrea"):     The record date will be 5 p.m.

Labcorp announces launch of Fortrea's Notes Offering in connection with anticipated spinoff

BURLINGTON, N.C. , June 8, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc. , a wholly owned subsidiary of Labcorp ("Fortrea"), has launched an offering of senior secured notes due 2030 (the "Notes"), subject to market

Labcorp Appoints Dr. Paul Rothman to Board of Directors

Health system executive brings three decades of medical enterprise experience to Labcorp BURLINGTON, N.C. , June 7, 2023 /PRNewswire/ --  Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent

Labcorp's planned spin-off, Fortrea, to host 2023 Investor Day

BURLINGTON, N.C. , June 5, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced Fortrea, the new company to be formed by the planned spin-off of Labcorp's Clinical Development and Commercialization Services business, will host its inaugural Investor Day

Labcorp Plasma Focus™ liquid biopsy test now available

Liquid biopsy tes t for cancer patients enables oncologists to identify targeted therapies and improve care BURLINGTON, N.C. , May 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted